Weekly update Companies AI-cruiter Recruiting service

NexImmune

Founded: 2011

Location: Gaithersburg, MD

Employee range: 11 - 50

Clinical stage: Clin1/Clin2

Therapy area: AML/MDS

Drug types: ONC, IMM, INF

Lead product: NEXI-001

Product link: https://neximmune.com/our-pipeline/

Funding: $126.5M IPO Feb 2021; $23M A Jan 2018

neximmune.com

linkedin.com

job board

Short description:

Artificially engineered antigen-presenting cells

Drug notes:

Also Clin0 multiple cancers; NEXI-002 Clin1 (paused Aug 2022) multiple myeloma, Clin0 autoimmune diseases; NEXI-003 Clin0/Clin1 HPV cancers, Clin0 infectious diseases; NEXI-004 Clin0 EBV diseases

Long description:

Jobs:

Main

Contact: recruit@workinbiotech.com